Simpson Thacher represented KKR in the sale of 3,450,000 shares of BridgeBio Pharma, Inc. The secondary offering, which was effected pursuant to a block trade, raised…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
